C-reactive protein levels in the early stage of COVID-19
Indexed incrossrefpubmed
Abstract
Background
COVID-19 is a new infectious disease, for which there is currently no treatment. It is therefore necessary to explore biomarkers to determine the extent of lung lesions and disease severity.
Objective
We aimed to assess the usefulness of CRP levels in the early stage of COVID-19 and to correlate them with lung lesions and severe presentation.
Citation impact
726
total citations
- FWCI
- 17.13
- Percentile
- 100%
- References
- 19
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Mann–Whitney U test
- Lesion
- Lung
- Medicine
- Internal medicine
- Gastroenterology
- Coronavirus disease 2019 (COVID-19)
- Stage (stratigraphy)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.